泰利福医疗

US · TFX #2082 按市值排名上市于 1970

130.43 +2.21 +1.72%

实时 - 追踪5344个代码 - 心跳于57秒前 · 2026-10-16 19:30

✦ 量化股权信号计算方式说明

涨跌不一/平稳

最近一期（2026/Q3）披露持股的机构数量增加了1家。
机构持股总比例基本持平。

机构持股

机构持股比例: 114.36% +0.05pp
机构数量: 452 +1
数据截至: 2026/Q3 较上一报告期

持股变动 vs 资金流向

方向分歧

机构在上一报告期增持了股份，同时该股在最近20个交易日的主力资金呈净流出——两者方向出现分歧。

机构持股变动数据按季度发布且存在滞后；资金流向数据为每日更新。请将其作为方向性的交叉验证参考，而非精确的择时信号。

持股人类型

Mutual Fund79.29%

Hedge Fund25.19%

Public Company4.97%

Sovereign Wealth Fund1.62%

Government Pension Fund1.57%

Private Company1.42%

Individual/Insider0.30%

Insurance Company0.11%

主要股东截至 2026-06-30

BlackRock 12.82% · 5.43M 股

Janus Henderson Group plc 10.25% · 4.34M 股

T. Rowe Price Group, Inc. 7.65% · 3.24M 股

Vanguard Portfolio Management, LLC 5.70% · 2.42M 股

Vanguard Capital Management, LLC 5.37% · 2.28M 股

Sessa Capital IM, L.P. 3.60% · 1.53M 股

State Street Global Advisors 3.50% · 1.48M 股

Millennium Management LLC 3.40% · 1.44M 股

The Baupost Group, L.L.C. 3.33% · 1.41M 股

Fuller & Thaler Asset Management, Inc. 3.12% · 1.32M 股

条形长度是相对于此处列出的最大股东而言，并非相对于公司100%股权。

内部人持股

共追踪50份申报 · 37次买入 · 10次卖出

姓名	职务	持股比例
Liam Kelly	Chairperson & CEO	0.10%
Thomas Powell	Chief Financial Officer	0.04%
Daniel Logue	Corporate VP, General Counsel & Secretary	0.03%
Cameron Hicks	Corporate Vice President of Human Resources & Communications	0.02%
Stephen Klasko	Independent Director	0.02%
Andrew Krakauer	Independent Director	0.02%
Gretchen Frances Haggerty	Independent Director	0.01%
Candace Duncan	Independent Director	0.01%
John Heinmiller	Independent Director	0.01%
Jaewon Ryu	Independent Director	0.01%

内部人交易最近的 Form 4 申报记录

日期	姓名	职务	类型	股数	价格
2026-09-07	Sean Salmon	Independent Director	Other Acquisition	+674	--
2026-09-07	Sean Salmon	Independent Director	Other Derivative Acquisition	+4,444	$137.00
2026-06-07	Stuart Randle	Independent Director	Other Acquisition	+5,658	--
2026-06-07	Stuart Randle	Independent Director	Other Derivative Acquisition	+2,192	$131.74
2026-06-07	Jason Weidman	Chief Executive Officer	Other Acquisition	+53,983	--
2026-06-07	Jason Weidman	Chief Executive Officer	Other Derivative Acquisition	+26,071	$131.74
2026-06-06	Stuart Randle	Independent Director	Sale to Issuer	-4,054	$129.84
2026-05-14	Gretchen Frances Haggerty	Independent Director	Other Acquisition	+1,090	--
2026-05-14	Gretchen Frances Haggerty	Independent Director	Other Derivative Acquisition	+2,397	$129.71
2026-05-14	Michael Tokich	Independent Director	Other Acquisition	+1,090	--
2026-05-14	Michael Tokich	Independent Director	Other Derivative Acquisition	+4,793	$129.71
2026-05-14	Andrew Krakauer	Independent Director	Other Acquisition	+1,090	--
2026-05-14	Andrew Krakauer	Independent Director	Other Derivative Acquisition	+2,397	$129.71
2026-05-14	Candace Duncan	Independent Director	Other Acquisition	+1,090	--
2026-05-14	Candace Duncan	Independent Director	Other Derivative Acquisition	+2,397	$129.71
2026-05-14	Jaewon Ryu	Independent Director	Other Acquisition	+1,090	--
2026-05-14	Jaewon Ryu	Independent Director	Other Derivative Acquisition	+2,397	$129.71
2026-05-14	Neena Patil	Independent Director	Other Acquisition	+1,090	--
2026-05-14	Neena Patil	Independent Director	Other Derivative Acquisition	+2,397	$129.71
2026-05-08	Stuart Randle	Independent Director	Sale to Issuer	-289	$133.06

Form 4 申报记录，每家公司显示最新的一批。"Other Derivative Acquisition"（其他衍生品获取）类目多为限制性股票/期权归属，并非公开市场买入——具体类型见"类型"列。

报价时间 2026-10-16 19:30:05 · 仅供参考，不构成投资建议，也未考虑您的具体情况。